NASDAQ: ZYXI - Zynex

Yield per half year: -8.06%
Sector: Healthcare

Company Analysis Zynex

Download the report: word Word pdf PDF

1. Summary

Advantages

  • The stock's return over the last year (0.4405%) is higher than the sector average (-33.16%).
  • The company's current efficiency (ROE=21.1%) is higher than the sector average (ROE=9.61%)

Disadvantages

  • Price (9.12 $) is higher than fair price (2.97 $)
  • Dividends (0%) are below the sector average (0.5496%).
  • Current debt level 43.62% has increased over 5 years from 0%.

Similar companies

Amgen

Alexion

ABIOMED

Gilead Sciences

2. Share price and performance

2.1. Share price

2.2. News

No news yet

2.3. Market efficiency

Zynex Healthcare Index
7 days 16.6% 1% 1.2%
90 days 15% -48.3% 7.8%
1 year 0.4% -33.2% 34.2%

ZYXI vs Sector: Zynex has outperformed the "Healthcare" sector by 33.6% over the past year.

ZYXI vs Market: Zynex has significantly underperformed the market by -33.77% over the past year.

Stable price: ZYXI is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: ZYXI with weekly volatility of 0.0085% over the past year.

3. Summary of the report

3.1. General

P/E: 39.51
P/S: 2.09

3.2. Revenue

EPS 0.2693
ROE 21.1%
ROA 6.9%
ROIC 22.49%
Ebitda margin 8.14%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Above fair price: The current price (9.12 $) is higher than the fair price (2.97 $).

Price is higher than fair: The current price (9.12 $) is 67.4% higher than the fair price.

4.2. P/E

P/E vs Sector: The company's P/E (39.51) is lower than that of the sector as a whole (48.77).

P/E vs Market: The company's P/E (39.51) is lower than that of the market as a whole (48.12).

4.2.1 P/E Similar companies

4.3. P/BV

P/BV vs Sector: The company's P/BV (8.34) is higher than that of the sector as a whole (4.82).

P/BV vs Market: The company's P/BV (8.34) is higher than that of the market as a whole (3.1).

4.3.1 P/BV Similar companies

4.4. P/S

P/S vs Sector: The company's P/S indicator (2.09) is lower than that of the sector as a whole (33.76).

P/S vs Market: The company's P/S indicator (2.09) is lower than that of the market as a whole (10.15).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

EV/Ebitda vs Sector: The company's EV/Ebitda (27.74) is higher than that of the sector as a whole (-22.12).

EV/Ebitda vs Market: The company's EV/Ebitda (27.74) is higher than that of the market as a whole (18.05).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Net Income

Yield Trend: Rising and has grown by 0.4884% over the last 5 years.

Earnings Slowdown: The last year's return (0%) is below the 5-year average return (0.4884%).

Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.16%).

5.4. ROE

ROE vs Sector: The company's ROE (21.1%) is higher than that of the sector as a whole (9.61%).

ROE vs Market: The company's ROE (21.1%) is higher than that of the market as a whole (10.88%).

5.5. ROA

ROA vs Sector: The company's ROA (6.9%) is higher than that of the sector as a whole (0.3359%).

ROA vs Market: The company's ROA (6.9%) is higher than that of the market as a whole (6.5%).

5.6. ROIC

ROIC vs Sector: The company's ROIC (22.49%) is higher than that of the sector as a whole (7.63%).

ROIC vs Market: The company's ROIC (22.49%) is higher than that of the market as a whole (10.79%).

6. Finance

6.1. Assets and debt

Debt level: (43.62%) is quite low in relation to assets.

Increasing debt: over 5 years, the debt has increased from 0% to 43.62%.

Excess of debt: The debt is not covered by net income, percentage 632.24%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Low yield: The dividend yield of the company 0% is below the average for the sector '0.5496%.

7.2. Stability and increase in payments

Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.7.

Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Dividend Coverage: Current payments from income (0.0308%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Insider Selling More insider purchases by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
14.11.2024 Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Sale 8.09 16 180 2 000
13.11.2024 Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Sale 8.37 16 740 2 000
12.11.2024 Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Sale 9.24 18 480 2 000
11.11.2024 Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Sale 9.09 18 180 2 000
08.11.2024 Sandgaard Thomas
PRESIDENT, CEO AND CHAIRMAN
Sale 8.77 17 540 2 000

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

9. Stocks forum Zynex

9.3. Comments